Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Gynecologic 3Breast 3Genitourinary 2CNS 2Tumor-Agnostic 1Sarcoma 1Dermatologic 1

Conditions

Breast Neoplasms 3Neoplasm Metastasis 1Central Nervous System Diseases 1Brain Neoplasms 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 467Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × sagopilone × Breast × Clear all
NCT00313248 2015-12-10

Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer

Bayer

Phase 2 Completed
65 enrolled
Breast

Breast Neoplasms

NCT00288249 2014-12-02

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer

Bayer

Phase 2 Completed
82 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00496379 2013-03-14

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

Dana-Farber Cancer Institute

Phase 2 Terminated
15 enrolled 10 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Central Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡